Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

Bursa Malaysia Clarification On QSR

Date 22/09/2005

We refer to the recent news articles relating to the QSR Brands Berhad (“QSR”) board tussle, in particular the article that appeared in The Sun on September 22, 2005 which quoted a statement by Datuk Johari Abdul Ghani that “the announcement to Bursa Malaysia on the removal of QSR’s nine directors was already recognized by the stock exchange and deemed official.”

Bursa wishes to clarify that one of Bursa’s roles is as a facility provider for the dissemination of listed issuers’ public announcements. In this regard, Bursa’s role is to disseminate announcements made by the listed issuers in accordance with the listing requirements.

Under Bursa’s procedure, companies are allowed to submit announcements through more than one access. In the case of QSR, the company used two accesses to make announcements. The second access was allowed pursuant to a request by the company duly signed by a director and supported by a board resolution authorizing the request and in accordance with Bursa’s procedures.

Given the conflicting statements by both parties on the validity of QSR’s Board of Directors, Bursa has requested both parties to each provide further information relating to this matter. Bursa expects to receive the information tomorrow and after an assessment will decide on any further action on its part. For the time being, Bursa will allow material information in accordance with the listing requirements to be disseminated via Bursa LINK.

Bursa wishes to reiterate that in its action of disseminating announcements by listed issuers, Bursa does not endorse, opine or make any judgements, representations or warranties of any kind in respect of the contents of the announcements including the veracity, completeness, accuracy and validity of the announcements. In this relation, listed issuers, their companies and their advisors are responsible for ensuring that the disclosure standard prescribed under the listing requirements is complied with.